it's still lower joining us is senior associate dean for leadership studies and cnbc contributor jeff sonnenfeldporate crises, where does this fall? judging by the stock price it looks severe, how would you characterize it? >>. >> i think it's an overreaction and a gross distortion you called it a bombshell investigation. it's a bombshell all right but there's no investigation it's a stapling together of the plaintiff's half-truths woven together in a misleading tapestry that doesn't tell the story. as you know, i've been partially critical of anybody from tesla to dennis kozlovski and the earliest days of enron, you name the scandal, theranos, i never mince words, i have no relationship with johnson & johnson, they've never offered me a dollar, they don't even appear at my events yet they are being badly treated here. >> what is so unfair >> what's so unsurface-to-air a mischaracterization of the research there's no researchi tal to ovarian cancer or mesothelioma any case where there's been a jury it's been overturned on appeal there's a newer case from this systemer, the reuters article talks